Consumption of a novel dietary formula of plant sterol esters of canola oil fatty acids, in a canola oil matrix containing 1,3-diacylglycerol, reduces oxidative stress in atherosclerotic apolipoprotein E-deficient mice

Journal of Agricultural and Food Chemistry

Volumn 55, Issue 5, 2007, Pages 2028-2033

  Fuhrman, Bianca ^a   Plat, Dorit ^b   Herzog, Yael ^b   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Enzymotec Ltd   (Israel)

Author keywords

Apo E mice; Canola oil; Diacylglycerol; Macrophage foam cells; Oxidative stress; Plant sterols

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; CANOLA OIL; DIACYLGLYCEROL; ESTER; FATTY ACID; LIPID; MONOUNSATURATED FATTY ACID; PHYTOSTEROL; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; BLOOD; CHEMISTRY; DIET; DRUG EFFECT; MOUSE; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET; DIGLYCERIDES; ESTERS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; LIPIDS; MICE; OXIDATIVE STRESS; PHYTOSTEROLS;

BRASSICA NAPUS; BRASSICA NAPUS VAR. NAPUS; MUS;

EID: 33947599374     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf062890t     Document Type: Article

References (30)

1. Eisenberg, D. The importance of lowering cholesterol in patients with coronary heart disease. Clin. Cardiol. 1998, 21, 81-4.
2. Aviram, M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic. Res. 2000, 33 Suppl, S85-97.
3. Aviram, M. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins. Antioxid. Redox Signal. 1999, 1, 585-94.
4. Liao, J. K. Endothelium and acute coronary syndromes. Clin. Chem. 1998, 44, 1799-808.
5. Aviram, M. HDL-associated paraoxonase 1 (PON1) and dietary antioxidants attenuate lipoprotein oxidation, macrophage foam cells formation and atherosclerosis development. Pathophysiol. Haemostasis Thromb. 2006, 35, 146-51.
6. Billecke, S.; Draganov, D.; Counsell, R.; Stetson, P.; Watson, C; Hsu, C; La, Du, B. N. Human serum paraoxonase (PON1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab. Dispos. 2000, 28, 1335-42.
7. Aviram, M.; Hardak, E.; Vaya, J.; Mahmood, S.; Milo, S.; Hoffman, A.; Billicke, S.; Draganov, D.; Rosenblat, M. Human serum paraoxonases (PON 1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000, 101, 2510-7.
8. Rozenberg, O.; Rosenblat, M.; Coleman, R.; Shih, D. M.; Aviram, M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic. Biol. Med. 2003, 34, 774-84.
9. Aviram, M.; Rosenblat, M.; Billecke, S.; Erogul, J.; Sorenson, R.; Bisgaier, C. L.; Newton, R. S.; La Du, B. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 1999, 26, 892-904.
10. Hamer, M.; Steptoe, A. Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: a systematic review. Br. J. Nutr. 2006, 95, 849-59.
11. Aviram, M.; Kaplan, M.; Rosenblat, M.; Fuhrman, B. Dietary antioxidants and paraoxonases against LDL oxidation and atherosclerosis development. Handb. Exp. Pharmacol. 2005, 170, 263-300.
12. Aviram, M.; Eias, K. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann. Nutr. Metab. 1993, 37, 75-84.
13. Katan, M. B.; Grundy, S. M.; Jones, P.; Law, M.; Miettinen, T.; Paoletti, R. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 2003, 78, 965-78.
14. Moghadasian, M. H. Pharmacological properties of plant sterols in vivo and in vitro observations. Life Sci. 2000, 67, 605-15.
15. Plump, A. S.; Smith, J. D.; Hayek, T.; Aalto-Setala, K.; Walsh, A.; Verstuyft, J. G.; Rubin, E. M.; Breslow, J. L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71, 343-53.
16. Basheer, S. Surfactant-lipase complex immobilized on insoluble matrix. US6605452, August 12, 2003.
17. Buege, J. A.; Aust, S. D. Microsomal lipid peroxidation. Methods Enzymol. 1978, 52, 302-10.
18. Aviram, M.; Dornfeld, L.; Rosenblat, M.; Volkova, N.; Kaplan, M.; Coleman, R.; Hayek, T.; Presser, D.; Fuhrman, B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 2000, 71, 1062-76.
19. Hayek, T.; Fuhrman, B.; Vaya, J.; Rosenblat, M.; Belinky, P.; Coleman, R.; Elis, A.; Aviram, M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 1997, 17, 2744-52.
20. Moruisi, K. G.; Oosthuizen, W.; Opperman, A. M. Phytosterols/ stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J. Am. Coll. Nutr. 2006, 25, 41-8.
21. Yeganeh, B.; Moshtaghi-Kashanian, G. R.; Declercq, V.; Moghadasian, M. H. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice. J. Nutr. Biochem. 2005, 16, 222-8.
22. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285, 2486-97.
23. Lukic, T.; Wasan, K. M.; Zamfir, D.; Moghadasian, M. H.; Pritchard, P. H. Disodium ascorbyl phytostanyl phosphate reduces plasma cholesterol concentrations and atherosclerotic lesion formation in apolipoprotein E-deficient mice. Metabolism 2003, 52, 425-31.
24. Ebine, N.; Jia, X.; Demonty, I.; Wang, Y.; Jones, P. J. Effects of a water-soluble phytostanol ester on plasma cholesterol levels and red blood cell fragility in hamsters. Lipids 2005, 40, 175-80.
25. Rudkowska, I.; Roynette, C. E.; Demonty, I.; Vanstone, C. A.; Jew, S.; Jones, P. J. Diacylglycerol: efficacy and mechanism of action of an anti-obesity agent. Obes. Res. 2005, 13, 1864-76.
26. Lavy, A.; Brook, G. J.; Dankner, G.; Ben, Amotz, A.; Aviram, M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism 1991, 40, 794-9.
27. Aviram, M.; Fuhrman, B. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants. Mol. Cell Biochem. 1998, 188, 149-59.
28. Homma, Y.; Ikeda, I.; Ishikawa, T.; Tateno, M.; Sugano, M.; Nakamura, H. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial. Nutrition 2003, 19, 369-74.
29. Summanen, J.; Yrjonen, T.; Christiansen, L.; Mervaala, E.; Vaskonen, T.; Lassila, M.; Ahotupa, M.; Yliruusi, J.; Karppanen, H.; Hiltunen, R. Effects of microcrystalline plant sterol suspen-sion and a powdered plant sterol supplement on hypercholes-terolemia in genetically obese Zucker rats. J. Pharm. Pharmacol. 2003, 55, 1673-9.
30. Van Rensburg, S. J.; Daniels, W. M.; van Zyl, J. M.; Taljaard, J. J. A comparative study of the effects of cholesterol, beta-sitosterol, beta-sitosterol glucoside, dehydroepiandrosterone sulphate and melatonin on in vitro lipid peroxidation. Metab. Brain Dis. 2000, 15, 257-65.